InterCure Ltd. (INCR)Healthcare | Drug Manufacturers - Specialty & Generic | Herzliya, Israel | NasdaqGM
0.99 USD
+0.04
(4.211%)
⇧
(July 14, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 6:12 a.m. EDT
InterCure presents a classic value trap with deteriorating fundamentals and no capital return to shareholders. While the company recently secured financing and reported a 43.8% revenue surge, the bottom line remains deeply unprofitable with negative free cash flow and a trailing P/E that is mathematically undefined due to losses. The balance sheet is fragile, with debt-to-equity nearing 46% and returns on both assets and equity significantly negative. The price action confirms this distress, as the stock has erased nearly 23% of its value over the last six years, finishing the period lower despite a single year of recovery. With no dividend to cushion the blow and a forward P/E suggesting the market expects further earnings deterioration, the investment case is weak. The recent financing round provides temporary liquidity but does not resolve the core operational bleed. This is a speculative hold at best, likely a cash grab for distressed investors, rather than a viable long-term compounder. |
| Model | MAE |
|---|---|
| MSTL_70 ✓ | 0.138432 |
| MSTL_70_105 | 0.183286 |
| AutoETS | 0.190545 |
| MSTL | 0.192763 |
| MSTL_105 | 0.212085 |
| AutoTheta | 0.216688 |
| AutoARIMA | 0.246820 |
Forecast horizon: 60 days | Selected: MSTL_70
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 5.76 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.192 |
| Excess Kurtosis | -0.40 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 46.174 |
| Market Cap | 56,580,872 |
| Forward P/E | -0.67 |
| Beta | 0.57 |
| Profit Margins | -13.22% |
| Website | https://www.intercure.co |
As of July 11, 2026, 6:12 a.m. EDT: Options activity is extremely thin with negligible open interest across all expirations. There is no meaningful positioning in either calls or puts to indicate a specific speculative bias. The lack of liquidity suggests the market is effectively absent from this name.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.33999997 |
| Address1 | 85 Medinat ha-Yehudim Street |
| All Time High | 9.99 |
| All Time Low | 0.3 |
| Ask | 1.03 |
| Ask Size | 11 |
| Average Daily Volume10 Day | 28,940 |
| Average Daily Volume3 Month | 57,904 |
| Average Volume | 57,904 |
| Average Volume10Days | 28,940 |
| Beta | 0.574 |
| Bid | 1.01 |
| Bid Size | 1 |
| Book Value | 7.591 |
| City | Herzliya |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.99 |
| Current Ratio | 1.478 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.0 |
| Day Low | 0.9662 |
| Debt To Equity | 46.174 |
| Display Name | InterCure |
| Earnings Timestamp End | 1,756,731,600 |
| Earnings Timestamp Start | 1,756,386,000 |
| Ebitda | -55,343,000 |
| Ebitda Margins | -0.20482 |
| Eps Forward | -1.48 |
| Eps Trailing Twelve Months | -0.22 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 972 9 768 0244 |
| Fifty Day Average | 0.95064 |
| Fifty Day Average Change | 0.039359987 |
| Fifty Day Average Change Percent | 0.04140367 |
| Fifty Two Week Change Percent | -33.999996 |
| Fifty Two Week High | 1.77 |
| Fifty Two Week High Change | -0.78 |
| Fifty Two Week High Change Percent | -0.44067794 |
| Fifty Two Week Low | 0.68 |
| Fifty Two Week Low Change | 0.31 |
| Fifty Two Week Low Change Percent | 0.45588234 |
| Fifty Two Week Range | 0.68 - 1.77 |
| Financial Currency | ILS |
| First Trade Date Milliseconds | 1,548,685,800,000 |
| Float Shares | 38,043,445 |
| Forward Eps | -1.48 |
| Forward P E | -0.6689189 |
| Free Cashflow | -37,432,376 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 285 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.15064 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.39173 |
| Held Percent Institutions | 0.01039 |
| Implied Shares Outstanding | 57,152,396 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ir Website | http://www.resperate.com/investor-relations/ |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. |
| Long Name | InterCure Ltd. |
| Market | us_market |
| Market Cap | 56,580,872 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_36626000 |
| Most Recent Quarter | 1,767,139,200 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 56,580,872 |
| Open | 0.99 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 972 7 746 05012 |
| Pre Market Change | -0.00999999 |
| Pre Market Change Percent | -0.99999905 |
| Pre Market Price | 0.99 |
| Pre Market Time | 1,784,117,131 |
| Previous Close | 0.95 |
| Price Hint | 4 |
| Price To Book | 0.1304176 |
| Profit Margins | -0.13216 |
| Quick Ratio | 0.91 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.04000002 |
| Regular Market Change Percent | 4.210529 |
| Regular Market Day High | 1.0 |
| Regular Market Day Low | 0.9662 |
| Regular Market Day Range | 0.9662 - 1.0 |
| Regular Market Open | 0.99 |
| Regular Market Previous Close | 0.95 |
| Regular Market Price | 0.99 |
| Regular Market Time | 1,784,059,200 |
| Regular Market Volume | 19,207 |
| Return On Assets | -0.05784 |
| Return On Equity | -0.092650004 |
| Revenue Growth | 0.239 |
| Sand P52 Week Change | 0.2043345 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 57,152,396 |
| Shares Percent Shares Out | 0.00029999999 |
| Shares Short | 15,144 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 27,374 |
| Short Name | Intercure Ltd. |
| Short Percent Of Float | 0.00029999999 |
| Short Ratio | 0.16 |
| Source Interval | 15 |
| Symbol | INCR |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.22 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.062335 |
| Two Hundred Day Average Change | -0.072335005 |
| Two Hundred Day Average Change Percent | -0.06809058 |
| Type Disp | Equity |
| Volume | 19,207 |
| Website | https://www.intercure.co |
| Zip | 4,676,670 |